Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
05/2007
05/31/2007US20070123570 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
05/31/2007US20070123531 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
05/31/2007CA2630860A1 Urea derivatives useful as calcium receptor modulators
05/31/2007CA2630234A1 Thrombopoietin activity modulating compounds and methods
05/31/2007CA2630039A1 Azetidine derivatives as glyt1 inhibitors
05/30/2007EP1789411A1 Novel anthranilamides useful for controlling invertebrate pests
05/30/2007EP1789396A1 Substituted phenylacetamides and their use as glucokinase activators
05/30/2007EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation
05/30/2007EP1003730B1 2-benzoyl-cyclohexane-1,3-diones
05/30/2007CN1972933A Heterocyclic carboxamides with microbiocidal activity
05/30/2007CN1972915A Anthranilamide insecticides
05/30/2007CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
05/29/2007US7223782 Pyrazole-amides and -sulfonamides
05/29/2007US7223774 Benzamide 2-hydroxy-3-diaminoalkanes
05/29/2007US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies
05/29/2007CA2299447C Procedure for obtaining the enantiomers of cyzolirtine
05/24/2007WO2007059157A1 Bisamide inhibitors of hedgehog signaling
05/24/2007WO2007058626A1 Indazole compounds
05/24/2007WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I
05/24/2007WO2007057139A1 Microbiocides
05/24/2007WO2007056955A1 Pyrazolopyrimidinone derivatives, their preparation and their use
05/24/2007WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound
05/24/2007WO2006081335A3 Process for preparing substituted 1- [3- ( pyrazolyl) phenyl] -3-phenyl ureas
05/24/2007US20070117857 Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators
05/24/2007US20070117856 Indazole derivatives
05/24/2007US20070117854 Malononitrile compounds and use thereof
05/24/2007US20070117852 (Hetero)cyclyl carboxanilides for controlling harmful fungi
05/24/2007US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis
05/24/2007CA2629814A1 Bisamide inhibitors of hedgehog signaling
05/24/2007CA2627365A1 Process for the production of carboxanilides
05/23/2007EP1787981A1 New N-phenethylcarboxamide derivatives
05/23/2007EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists
05/23/2007EP1786779A1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
05/23/2007EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
05/23/2007EP1786424A2 Lonidamine analogues and their use in male contraception and cancer treatment
05/23/2007EP1585743B1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
05/23/2007EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
05/23/2007CN1968936A Cationic dyes and dyestuff for keratin fibres, containing said compounds
05/23/2007CN1968935A 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (ortho-phenyl)-anilides and to use thereof as fungicide
05/23/2007CN1968934A 1-methyl-3-difluoromethyl-pyrazol-4-carbonic acid-(ortho-phenyl)-anilides, and use thereof as a fungicide
05/23/2007CN1968933A Pyrazole derivatives useful for the treatment of cancer
05/23/2007CN1968928A Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
05/23/2007CN1317273C Compound having thiofuran and acetylene ethylene bond, its preparation method and use
05/23/2007CN1317264C Process for the preparation of phenyl pyrazole compounds
05/22/2007US7220867 Dissolving with crystal growth inihibitos; drying
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220772 Pyrazole derivatives
05/22/2007US7220771 Jun n-terminal kinase inhibitors
05/22/2007US7220745 Viricides; therapy for hepatitis virus infections
05/22/2007CA2301093C Fluoropyrazole-biphenylamide fungicides
05/22/2007CA2281892C Processes for preparing pesticidal intermediates
05/22/2007CA2276694C New fatty acid derivatives
05/22/2007CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds
05/22/2007CA2157146C Heterocyclyl-benzoylguanidines
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007056091A2 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
05/18/2007WO2007054770A2 Pyrazole derivatives and their medical use
05/18/2007WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007CA2628260A1 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
05/17/2007US20070112192 3-(2-Hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
05/17/2007US20070112037 Pyrazole Derivatives
05/17/2007US20070112036 Opioid receptor antagonists
05/17/2007US20070112006 such as (7-methyl-5-trifluoromethyl-1,2,4-triazolo[1,5-a]pyrimidin-2-yl)-[3-(2-(N-methylaminocarbonyl)pyridin-4yloxy)phenyl]amine, used as tyrosine kinase inhibitors for the treatment of tumors
05/16/2007EP1784383A1 Method for the production of biphenylamines
05/16/2007EP1784178A1 Aryl (or heteroaryl) azolylcarbinols
05/16/2007EP1465638B1 Phosphate transport inhibitors
05/16/2007CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof
05/16/2007CN1964947A Pyrazole derivatives, compositions containing such compounds and methods of use
05/16/2007CN1964718A Leptomycin compounds
05/16/2007CN1962640A Synthesis of n2 - (substituted arylmethyl) -3- (substituted phenyl) indazoles as novel anti-angiogenic agents
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/15/2007US7217740 Diarylsulfones as 5-HT2A antagonists
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
05/15/2007US7217697 Sodium dependent glucose transporter 1 inhibitors; blocking small intestine absorption of glucose; diabetes
05/10/2007WO2007052843A1 Heterocyclic amide compound and use thereof
05/10/2007WO2007052000A1 Pyrazoles useful in the treatment of inflammation
05/10/2007WO2007033366A3 Biphenyl-pyrazolecarboxamide compounds
05/10/2007WO2006138373A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
05/10/2007WO2006088903A3 Pyrazole compounds
05/10/2007US20070106081 Bicyclic derivatives as ppar modulators
05/10/2007US20070105932 2H-or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/10/2007US20070105913 Alkynyl aryl carboxamides
05/10/2007US20070105909 Compounds useful in therapy
05/10/2007US20070105871 1,3,4-Substituted pyrazoles as 5-ht receptor antagonists for the treatment of psychoses and neurological disorders
05/09/2007EP1783110A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
05/09/2007EP1781668A2 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
05/09/2007EP1781661A2 Vasopressin v1a antagonists
05/09/2007EP1781630A1 Novel piperidine derivative for the treatment of depression
05/09/2007EP1781619A1 Sigma receptor inhibitors
05/09/2007EP1781618A1 Sigma receptor inhibitors
05/09/2007EP1781617A2 Alpha, beta-unsaturated esters and acids by stereoselective dehydration
05/09/2007EP1781614A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
05/09/2007EP1558203B1 Hair treatment composition containing a styryl-pyrazole compound
05/09/2007EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
05/09/2007CN1960976A 4-carbox pyrazole derivates useful as anti-viral agents
05/09/2007CN1958573A Method for preparing compound of 1, 2 (dodecyl) 4 hydroxide methylene ¿C 3, 5 pyrazole
05/08/2007US7214802 Anti-cytokine heterocyclic compounds